LONDON (Thomson Financial) - Prostrakan PLC, the Scottish specialty biotech company, has announced that Peter Allen, a non-executive director since 2005, is to succeed Harry Stratford as Chairman after Stratford retires at the end of this year.
LONDON (Thomson Financial) - Prostrakan PLC, the Scottish specialty biotech company, has announced that Peter Allen, a non-executive director since 2005, is to succeed Harry Stratford as Chairman after Stratford retires at the end of this year.
